G protein-coupled receptor 40 (GPR40) and peroxisome proliferator-activated receptor γ (PPARγ): An integrated two-receptor signaling pathway

Journal of Biological Chemistry

Volumn 290, Issue 32, 2015, Pages 19544-19557

  Wang, Shuibang ^a   Awad, Keytam S ^a   Elinoff, Jason M ^a   Dougherty, Edward J ^a   Ferreyra, Gabriela A ^a   Wang, Jennifer Y ^a   Cai, Rongman ^a   Sun, Junfeng ^a   Ptasinska, Anetta ^a,b   Danner, Robert L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; CHEMICAL ACTIVATION; CYTOLOGY; ENDOTHELIAL CELLS; FATTY ACIDS; PHOSPHORYLATION; PROTEINS; RATIONAL FUNCTIONS; SIGNAL TRANSDUCTION; SIGNALING;

G PROTEIN COUPLED RECEPTORS; GENE TRANSCRIPTIONS; GLUCOSE HOMEOSTASIS; HUMAN ENDOTHELIAL CELLS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PULMONARY ARTERY ENDOTHELIAL CELLS; RECEPTOR SIGNALING; TYPE 2 DIABETES MELLITUS;

TRANSCRIPTION;

E1A ASSOCIATED P300 PROTEIN; G PROTEIN COUPLED RECEPTOR 40; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; ROSIGLITAZONE; SIRTUIN 1; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DNA; EP300 PROTEIN, HUMAN; FFAR1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; LIGAND; LUCIFERASE; PIOGLITAZONE; PPARGC1A PROTEIN, HUMAN; PROTEIN BINDING; SIRT1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PULMONARY ARTERY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRIMARY CELL CULTURE; REPORTER GENE;

CELL LINE; DNA; E1A-ASSOCIATED P300 PROTEIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; HYPOGLYCEMIC AGENTS; LIGANDS; LUCIFERASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; PRIMARY CELL CULTURE; PROTEIN BINDING; RECEPTOR CROSS-TALK; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84939235405     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.638924     Document Type: Article

References (56)

1. Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., Pignone, M. P., Plutzky, J., Porte, D., Redberg, R., Stitzel, K. F., and Stone, N. J., American Heart Association, and American Diabetes Association (2007) Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115, 114-126
2. Yki-Järvinen, H. (2004) Thiazolidinediones. N. Engl. J. Med. 351, 1106-1118
3. McGuire, D. K., and Inzucchi, S. E. (2008) New drugs for the treatment of diabetes mellitus: part I: thiazolidinediones and their evolving cardiovascular implications. Circulation 117, 440-449
4. Ketsawatsomkron, P., Pelham, C. J., Groh, S., Keen, H. L., Faraci, F. M., and Sigmund, C. D. (2010) Does peroxisome proliferator-activated receptor-γ (PPARγ) protect from hypertension directly through effects in the vasculature? J. Biol. Chem. 285, 9311-9316
5. Goldberg, R. B., Kendall, D. M., Deeg, M. A., Buse, J. B., Zagar, A. J., Pinaire, J. A., Tan, M. H., Khan, M. A., Perez, A. T., Jacober, S. J., and GLAI Study Investigators (2005) A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 28, 1547-1554
6. Wang, N., Verna, L., Chen, N. G., Chen, J., Li, H., Forman, B. M., and Stemerman, M. B. (2002) Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J. Biol. Chem. 277, 34176-34181
7. Erdmann, E., Spanheimer, R., Charbonnel, B., and PROactive Study Investigators (2010) Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20). J. Diabetes 2, 212-220
8. Hansmann, G., de Jesus Perez, V. A., Alastalo, T. P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., and Rabinovitch, M. (2008) An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J. Clin. Invest. 118, 1846-1857
9. Reddy, R. C., Narala, V. R., Keshamouni, V. G., Milam, J. E., Newstead, M. W., and Standiford, T. J. (2008) Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γ. Blood 112, 4250-4258
10. Kahn, B. B., and McGraw, T. E. (2010) Rosiglitazone, PPARγ, and type 2 diabetes. N. Engl. J. Med. 363, 2667-2669
11. Spiegelman, B. M. (1998) PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507-514
12. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., and Glass, C. K. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437, 759-763
13. Hu, E., Kim, J. B., Sarraf, P., and Spiegelman, B. M. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 2100-2103
14. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A., and Chatterjee, V. K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132
15. Camp, H. S., and Tafuri, S. R. (1997) Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816
16. Rangwala, S. M., Rhoades, B., Shapiro, J. S., Rich, A. S., Kim, J. K., Shulman, G. I., Kaestner, K. H., and Lazar, M. A. (2003) Genetic modulation of PPARγ phosphorylation regulates insulin sensitivity. Dev. Cell 5, 657-663
17. Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S., Boström, P., Laznik, D., Ruas, J. L., Chalmers, M. J., Kamenecka, T. M., Blüher, M., Griffin, P. R., and Spiegelman, B. M. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466, 451-456
18. Puigserver, P., Rhee, J., Lin, J., Wu, Z., Yoon, J. C., Zhang, C. Y., Krauss, S., Mootha, V. K., Lowell, B. B., and Spiegelman, B. M. (2001) Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1. Mol. Cell 8, 971-982
19. Fan, M., Rhee, J., St-Pierre, J., Handschin, C., Puigserver, P., Lin, J., Jäeger, S., Erdjument-Bromage, H., Tempst, P., and Spiegelman, B. M. (2004) Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK. Genes Dev. 18, 278-289
20. Teruel, T., Hernandez, R., Benito, M., and Lorenzo, M. (2003) Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. J. Biol. Chem. 278, 263-269
21. Cao, W., Daniel, K. W., Robidoux, J., Puigserver, P., Medvedev, A. V., Bai, X., Floering, L. M., Spiegelman, B. M., and Collins, S. (2004) p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Mol. Cell. Biol. 24, 3057-3067
22. Bratton, M. R., Frigo, D. E., Vigh-Conrad, K. A., Fan, D., Wadsworth, S., McLachlan, J. A., and Burow, M. E. (2009) Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase. Carcinogenesis 30, 106-113
23. Lerin, C., Rodgers, J. T., Kalume, D. E., Kim, S. H., Pandey, A., and Puigserver, P. (2006) GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α. Cell Metab. 3, 429-438
24. Nemoto, S., Fergusson, M. M., and Finkel, T. (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J. Biol. Chem. 280, 16456-16460
25. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113-118
26. Sohda, T., Mizuno, K., Tawada, H., Sugiyama, Y., Fujita, T., and Kawamatsu, Y. (1982) Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds. Chem. Pharm. Bull. 30, 3563-3573
27. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995) 15-Deoxy-δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812
28. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., and Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956
29. Zhou, C., Tang, C., Chang, E., Ge, M., Lin, S., Cline, E., Tan, C. P., Feng, Y., Zhou, Y. P., Eiermann, G. J., Petrov, A., Salituro, G., Meinke, P., Mosley, R., Akiyama, T. E., Einstein, M., Kumar, S., Berger, J., Howard, A. D., Thornberry, N., Mills, S. G., and Yang, L. (2010) Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists. Bioorg. Med. Chem. Lett. 20, 1298-1301
30. Kotarsky, K., Nilsson, N. E., Flodgren, E., Owman, C., and Olde, B. (2003) A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem. Biophys. Res. Commun. 301, 406-410
31. Smith, N. J., Stoddart, L. A., Devine, N. M., Jenkins, L., and Milligan, G. (2009) The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1. J. Biol. Chem. 284, 17527-17539
32. Gras, D., Chanez, P., Urbach, V., Vachier, I., Godard, P., and Bonnans, C. (2009) Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L970-L978
33. Mieczkowska, A., Baslé, M. F., Chappard, D., and Mabilleau, G. (2012) Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism. J. Biol. Chem. 287, 23517-23526
34. 35S]thio)triphosphate binding studies reflects binding of an endogenous agonist. Mol. Pharmacol. 71, 994-1005
35. Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., and Fujino, M. (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173-176
36. Alquier, T., Peyot, M. L., Latour, M. G., Kebede, M., Sorensen, C. M., Gesta, S., Ronald Kahn, C., Smith, R. D., Jetton, T. L., Metz, T. O., Prentki, M., and Poitout, V. (2009) Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets. Diabetes 58, 2607-2615
37. Kim, H. S., Noh, J. H., Hong, S. H., Hwang, Y. C., Yang, T. Y., Lee, M. S., Kim, K. W., and Lee, M. K. (2008) Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression. Biochem. Biophys. Res. Commun. 367, 623-629
38. Yang, C., Chang, T. J., Chang, J. C., Liu, M. W., Tai, T. Y., Hsu, W. H., and Chuang, L. M. (2001) Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. Diabetes 50, 2598-2602
39. Ptasinska, A., Wang, S., Zhang, J., Wesley, R. A., and Danner, R. L. (2007) Nitric oxide activation of peroxisome proliferator-activated receptor γ through a p38 MAPK signaling pathway. FASEB J. 21, 950-961
40. Hata, K., Nishimura, R., Ikeda, F., Yamashita, K., Matsubara, T., Nokubi, T., and Yoneda, T. (2003) Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor γ during bone morphogenetic protein 2-induced adipogenesis. Mol. Biol. Cell 14, 545-555
41. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., and Evans, R. M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774
42. Yeo, S. J., Gravis, D., Yoon, J. G., and Yi, A. K. (2003) Myeloid differentiation factor 88-dependent transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: role of NF-κB and p38. J. Biol. Chem. 278, 22563-22573
43. 16 J. Biol. Chem. 275, 71-76
44. Ge, K., Cho, Y. W., Guo, H., Hong, T. B., Guermah, M., Ito, M., Yu, H., Kalkum, M., and Roeder, R. G. (2008) Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor γ-stimulated adipogenesis and target gene expression. Mol. Cell. Biol. 28, 1081-1091
45. Chu, K. M., Hu, O. Y., Pao, L. H., and Hsiong, C. H. (2007) Pharmacokinetics of oral rosiglitazone in Taiwanese and post hoc comparisons with Caucasian, Japanese, Korean, and mainland Chinese subjects. J. Pharm. Pharm. Sci. 10, 411-419
46. Camp, H. S., Li, O., Wise, S. C., Hong, Y. H., Frankowski, C. L., Shen, X., Vanbogelen, R., and Leff, T. (2000) Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone. Diabetes 49, 539-547
47. Maciag, A. E., Holland, R. J., Robert Cheng, Y. S., Rodriguez, L. G., Saavedra, J. E., Anderson, L. M., and Keefer, L. K. (2013) Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance. Redox. Biol. 1, 115-124
48. Akimoto, T., Pohnert, S. C., Li, P., Zhang, M., Gumbs, C., Rosenberg, P. B., Williams, R. S., and Yan, Z. (2005) Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 280, 19587-19593
49. Bordicchia, M., Liu, D., Amri, E. Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., and Collins, S. (2012) Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122, 1022-1036
50. Puigserver, P., Adelmant, G., Wu, Z., Fan, M., Xu, J., O'Malley, B., and Spiegelman, B. M. (1999) Activation of PPARγ coactivator-1 through transcription factor docking. Science 286, 1368-1371
51. Gelman, L., Zhou, G., Fajas, L., Raspé, E., Fruchart, J. C., and Auwerx, J. (1999) p300 interacts with the N- and C-terminal part of PPARγ2 in a ligand-independent and -dependent manner, respectively. J. Biol. Chem. 274, 7681-7688
52. Wang, Q. E., Han, C., Zhao, R., Wani, G., Zhu, Q., Gong, L., Battu, A., Racoma, I., Sharma, N., and Wani, A. A. (2013) p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res. 41, 1722-1733
53. Handschin, C., and Spiegelman, B. M. (2006) Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27, 728-735
54. Maekawa, T., Jin, W., and Ishii, S. (2010) The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Mol. Cell. Biol. 30, 613-625
55. Lennon, A. M., Ramaugé, M., Dessouroux, A., and Pierre, M. (2002) MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Δ(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor γ-independent mechanisms involving reactive oxygenated species. J. Biol. Chem. 277, 29681-29685
56. Duan, S. Z., Ivashchenko, C. Y., Russell, M. W., Milstone, D. S., and Mortensen, R. M. (2005) Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice. Circ. Res. 97, 372-379